- Home
- CULP vs IKNA Comparison
CULP vs IKNA Comparison
Compare CULP & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CULP
- IKNA
- Stock Information
- Founded
- CULP 1972
- IKNA 2016
- Country
- CULP United States
- IKNA United States
- Employees
- CULP N/A
- IKNA N/A
- Industry
- CULP Textiles
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- CULP Consumer Discretionary
- IKNA Health Care
- Exchange
- CULP Nasdaq
- IKNA Nasdaq
- Market Cap
- CULP 66.4M
- IKNA 64.7M
- IPO Year
- CULP N/A
- IKNA 2021
- Fundamental
- Price
- CULP $5.04
- IKNA $1.28
- Analyst Decision
- CULP
- IKNA Buy
- Analyst Count
- CULP 0
- IKNA 2
- Target Price
- CULP N/A
- IKNA $3.00
- AVG Volume (30 Days)
- CULP 37.5K
- IKNA 84.9K
- Earning Date
- CULP 03-05-2025
- IKNA 03-06-2025
- Dividend Yield
- CULP N/A
- IKNA N/A
- EPS Growth
- CULP N/A
- IKNA N/A
- EPS
- CULP N/A
- IKNA N/A
- Revenue
- CULP $213,993,000.00
- IKNA N/A
- Revenue This Year
- CULP $1.94
- IKNA N/A
- Revenue Next Year
- CULP $10.13
- IKNA N/A
- P/E Ratio
- CULP N/A
- IKNA N/A
- Revenue Growth
- CULP N/A
- IKNA N/A
- 52 Week Low
- CULP $4.20
- IKNA $1.22
- 52 Week High
- CULP $6.85
- IKNA $1.94
- Technical
- Relative Strength Index (RSI)
- CULP 45.39
- IKNA 39.30
- Support Level
- CULP $5.15
- IKNA $1.27
- Resistance Level
- CULP $5.57
- IKNA $1.43
- Average True Range (ATR)
- CULP 0.27
- IKNA 0.07
- MACD
- CULP -0.00
- IKNA -0.00
- Stochastic Oscillator
- CULP 19.71
- IKNA 18.60
About CULP Culp Inc.
Culp Inc manufactures, sources, and markets mattress fabrics and sewn covers used for covering mattresses and box springs and upholstery fabrics including cut and sewn kits used in the production of upholstered furniture. The company has two operating segments Mattress fabrics which generates maximum revenue, and Upholstery fabrics. The mattress fabrics segment, also known as Culp Home Fashions, manufactures and markets mattress fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment markets fabrics for residential, commercial, and hospitality furniture and also provides window treatment products and installation services for its customers in the hospitality and commercial industries. Geographically, it derives key revenue from the United States of America.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.